Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
about
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumabSunitinib in solid tumorsThe Effect of Snail1 Gene Silencing by siRNA in Metastatic Breast Cancer Cell Lines.The 2009-2013 research agenda for oncology nursing.Targeted Therapies in Lung Cancer.Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.Hormonal contraception and risk of cancer.miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancerCatecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders.TRAIL treatment provokes mutations in surviving cells.The role of bendamustine in the treatment of indolent non-Hodgkin lymphomaLocal breast cancer spatial patterning: a tool for community health resource allocation to address local disparities in breast cancer mortality.Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901.Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer SurvivorsKRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patientsConsultation etiquette in general practice: a qualitative study of what makes it different for lay cancer caregivers.Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.Creating community-academic partnerships for cancer disparities research and health promotion.The clinical consequences of an ageing world and preventive strategiesBreast cancer recurrence in older women five to ten years after diagnosis.Early detection of breast cancer: new biomarker tests on the horizon?Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.Clinical outcomes based on multigene profiling in metastatic breast cancer patientsMolecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations.Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells.SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line.Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo.Lifestyle behaviors among US cancer survivors.Chemopreventive effect of Lagenaria siceraria in two stages DMBA plus croton oil induced skin papillomagenesis.A sequence labeling approach to link medications and their attributes in clinical notes and clinical trial announcements for information extraction.Repeated Pancreatectomy for Recurrent Pancreatic Carcinoma after Pylorus-Preserving Pancreatoduodenectomy: Report of Two Patients.Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.Factors associated with perceptions of the cancer care system: a multilevel modeling approach.Downregulation of liver-intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells.New oral targeted therapies for metastatic breast cancer disrupt the traditional patients' management-A healthcare providers' view.Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas.
P2860
Q24594725-53E48BEB-5CF1-4B4B-A12A-01EF74FF23B2Q28245467-7C0B35C5-A402-41B7-AAAE-01EBBF7AF730Q33720686-A265AAF4-0587-42AB-8D96-E6D0930BAA7FQ33750499-0313C6CE-D2C6-43DB-80E0-02D3B4C24407Q34030379-DA4B6F38-F246-45C2-BE65-20A2FE1A1DA9Q34035015-95DC6E2B-B80E-4B52-A533-5E3FD9DE0DD6Q34120493-B11F636C-9487-4038-8461-BAF0D59B2B2FQ34136203-7ED4828E-6FB4-47B3-B6F4-899DE339D354Q34192568-E5E506E1-DB30-4F29-BE24-BA033739FE1BQ34243610-68F43DAF-8C22-44D9-A9BA-FE7A1EAA330FQ34353920-BFFD19C0-F282-4993-AC3E-8450E627409DQ34383454-E1A981CD-09D7-45E3-8DE9-EEB726D180A4Q34418442-8FAFA359-66B6-46E9-9AB8-189D2E57BBC6Q34428438-C124D800-B349-4620-BE29-DC7D2C20883FQ34488684-A1A40C85-9D6F-4C5F-B041-82D7FC4B706AQ35127004-E80C5C39-F211-4E51-BBF2-DDFB53A60DBEQ35128042-35FDE6BF-62DC-471B-9C8D-629C55AA4F8CQ35144608-3D555274-D0F6-4DA5-8855-5300F64C30DBQ35412921-C9E0CC6E-6AD5-4139-908D-CFC800965266Q35632213-3D86899A-E535-4F32-8347-E259ADC895C3Q36842861-E0179021-08E5-41E4-BC26-5B7C49C17786Q37179582-F0EA5819-B3D4-463A-9BE6-940A6F0C6D84Q37442431-A7B748E1-3C35-48B2-A860-330566F744D9Q37635097-99435776-0B13-49F0-8732-1D610D574EC5Q37697540-4612B348-B4C5-4DF0-BEBA-C1940EEF2B55Q37718221-A0BE94B5-6A53-4817-8161-89F046D26952Q38117105-8D40F9E0-8E32-4126-A524-77633C75954BQ38700109-9DFF62FF-9E7D-4E97-95AA-9B36F312F60BQ38763331-2E698300-4768-4860-9862-18D81E59E76EQ39701670-7FB8B641-A554-4252-94A3-FF30750902B9Q40049891-87281043-FCED-4CD2-9629-12E4018058C0Q40239172-BAFE3E6E-B62E-4188-B816-4901007AA292Q42058362-1C64D42A-9CC3-488E-99D8-0553110CE659Q42274029-C02D8908-935A-43D3-A725-110A92EB959BQ42927824-3A15E931-455D-466A-A9F1-F349E1375660Q43211029-7AFC8A79-1701-4F73-B598-929BC697724FQ44815202-FE8522BC-9EF6-42B7-81CE-2EEA9716B37CQ47331787-54E4469C-914F-4A8F-B324-9395991943B1Q48115704-877ED1EB-6CD4-4FBE-B2BF-76AD05E77C3FQ51607504-EA97075C-DF4B-4F79-92EF-218A472A54F3
P2860
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical cancer advances 2008: ...... n Society of Clinical Oncology
@en
Clinical cancer advances 2008: ...... Society of Clinical Oncology.
@nl
type
label
Clinical cancer advances 2008: ...... n Society of Clinical Oncology
@en
Clinical cancer advances 2008: ...... Society of Clinical Oncology.
@nl
prefLabel
Clinical cancer advances 2008: ...... n Society of Clinical Oncology
@en
Clinical cancer advances 2008: ...... Society of Clinical Oncology.
@nl
P2093
P2860
P356
P1476
Clinical cancer advances 2008: ...... n Society of Clinical Oncology
@en
P2093
Barnett Kramer
Beth Karlan
David Pfister
Derek Raghavan
Eric Winer
George Demetri
Gregory Reaman
Howard Sandler
John Sweetenham
Julie Gralow
P2860
P304
P356
10.1200/JCO.2008.21.2134
P407
P577
2008-12-22T00:00:00Z